The Lundquist Institute holds both U.S. and international patents for this humanized antibody and has granted Vitalex, a Lundquist spin-off company, the commercial rights to advance this therapeutic ...
A new study offers hope in the fight against flesh-eating fungus infections. Researchers have discovered a promising antibody ...
News Medical on MSN15h
Antibody-Based Therapy Shows Promise Against Lethal Fungal InfectionEarly tests suggest that an antibody-based therapy is safe, with no harmful effects on healthy cells, suggesting that it ...
Mucormycosis, a fungus infection caused by Mucorales, has a high mortality rates in those with weakened immune systems and ...
A deadly "flesh-eating" fungus is spreading rapidly in the US, posing a serious threat to people with weakened immune systems ...
Weʼre Not There Yet, but Weʼre Headed in the Right Direction: The Promise of AI in Clinical Medicine
The Promise of AI in Clinical Medicine | AI is Transforming Medicine: A Doctorʼs Perspective on Its Impact and Future ...
Advt Ashraf Ibrahim, PhD, an investigator at The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center ... and considered a medical emergency that needs immediate attention ...
We’re not there yet, but we’re headed in the right direction: The promise of AI in clinical medicine
He earned his medical degree from UCSF and completed his emergency medicine residency at Harbor-UCLA. An administrative fellow at Vituity, he specialized in CMS quality programs. Dr. Miller also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback